Published in Kidney Int on May 01, 1986
Perindopril. A review of its pharmacokinetics and clinical pharmacology. Drugs (1990) 0.91
Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension. Mol Med (2008) 0.85
Renin, endothelial NO synthase and endothelin gene expression in the 2kidney-1clip Goldblatt model of long-term renovascular hypertension. Eur J Med Res (2009) 0.75
Angiotensin and the remodelling of the myocardium. Br J Clin Pharmacol (1989) 0.75
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res (1992) 3.95
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet (1992) 3.33
Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem (1991) 3.22
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A (1988) 3.21
The number needed to treat: a clinically useful nomogram in its proper context. BMJ (1996) 2.89
Pefloxacin as first-line treatment in nephrotic syndrome. Lancet (1992) 2.58
Elastase-induced experimental aneurysms in rats. Circulation (1990) 2.50
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension (1994) 2.41
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet (2001) 2.28
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest (1996) 2.20
Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology (1972) 2.13
Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol (2000) 2.07
Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int (2006) 2.07
A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int (2000) 2.01
Mesangial IgA deposits in two patients with AIDS-related complex. Nephron (1990) 1.92
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ (1988) 1.91
The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem (1998) 1.91
The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem (1991) 1.86
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies. Am J Transplant (2010) 1.86
Complete amino acid sequence and maturation of the mouse submaxillary gland renin precursor. Nature (1982) 1.83
Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett (2000) 1.82
Hypoxia enhances Ecto-5'-Nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids. Circ Res (2003) 1.76
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant (2009) 1.67
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant (2011) 1.66
Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem (1991) 1.65
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol (1997) 1.65
Do physicians estimate reliably the cardiovascular risk of hypertensive patients?. Medinfo (1995) 1.62
Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res (1983) 1.62
The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem (1995) 1.58
Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int (2001) 1.57
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant (2011) 1.57
Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am J Physiol (1986) 1.55
Cardiac pheochromocytomas. Ann Thorac Surg (1992) 1.55
Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab (1997) 1.52
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant (2009) 1.52
Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem (2001) 1.51
Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem (1996) 1.49
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant (2007) 1.49
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest (1997) 1.48
Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possible involvement of bFGF. Cardiovasc Res (2000) 1.48
Multiple forms of human renin. Purification and characterization. J Biol Chem (1979) 1.45
Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med (Berl) (2001) 1.43
Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. J Am Coll Cardiol (1990) 1.43
The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem (1992) 1.42
Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients. Infect Dis (Lond) (2015) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Maturation-dependent changes of angiotensin receptor expression in fowl. Am J Physiol Regul Integr Comp Physiol (2003) 1.41
[Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients]. Nephrologie (1997) 1.41
Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int (2006) 1.40
ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol Cell Biol (1996) 1.39
Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. J Urol (1995) 1.39
Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res (2005) 1.39
Can echocardiography identify mildly hypertensive patients at high risk, left untreated based on current guidelines? J Hypertens (1999) 1.38
Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension (1994) 1.38
Identification of the rat adapter Grb14 as an inhibitor of insulin actions. J Biol Chem (1998) 1.38
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J Biol Chem (1994) 1.35
Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension (1997) 1.31
Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension (1993) 1.29
Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ Res (1996) 1.29
Association of overt glomerulonephritis and liver disease: a study of 34 patients. Clin Nephrol (1976) 1.28
Molecular cloning of genes encoding branched-chain keto acid dehydrogenase of Pseudomonas putida. J Bacteriol (1987) 1.28
Structure of human angiotensinogen gene. DNA (1989) 1.28
Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav (1993) 1.28
Benefits of a computer-assisted education program for hypertensive patients compared with standard education tools. Patient Educ Couns (1995) 1.27
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A (1996) 1.26
Species distribution of testosterone-binding globulin. Biol Reprod (1973) 1.26
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res (1988) 1.24
Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet (1997) 1.24
Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension (1994) 1.24
Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant (2007) 1.24
Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med (1991) 1.23
Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet (1997) 1.23
Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. Br J Pharmacol (1997) 1.23
Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest (1992) 1.23
Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol (1996) 1.22
Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol (1998) 1.22
The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett (1989) 1.22
Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab (1982) 1.22
Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab Invest (1994) 1.22
Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology (2008) 1.21
Role of angiotensinogen in blood pressure homeostasis. Hypertension (1982) 1.21
Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res (1999) 1.21
How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures? Hum Gene Ther (2001) 1.21
Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int (1998) 1.21
A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem (1995) 1.19
Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry (1998) 1.18
Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension (1996) 1.18
Mechanism of renin release following furosemide diuresis in rabbit. Am J Physiol (1968) 1.17
Arterial expansive remodeling induced by high flow rates. Am J Physiol (1997) 1.17
Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol (2000) 1.16
Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci U S A (1988) 1.16
Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci U S A (1992) 1.16
Use of a specific antiserum for renin detection in human kidney. J Histochem Cytochem (1980) 1.15